Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,770 results for "Product Liability Law & Strategy"...

Corporate Criminal Liability
January 29, 2013
While the government is busy holding businesses liable for criminal conduct, skeptics remain critical of its methods.
Cybersecurity Legislation Near
December 27, 2012
On Nov. 15, the U.S. Senate declined to approve S. 3414, the Cybersecurity Act of 2012. The proposed legislation would have set voluntary cybersecurity standards for owners of the nation's critical infrastructure, such as gas pipelines, utilities and banks. In the absence of cybersecurity legislation, the Obama administration now is considering taking action through an executive order.
Applying Patent Teachings in Product Liability Cases
December 27, 2012
In a product liability design defect action, evidence establishing the defectiveness of a product is paramount to a plaintiff's case. Conducting a patent search and an investigation of the state of the patent art may yield fruitful evidence regarding the defect or relative safety of the product at issue in a product liability action. But first some background to set the environment for how patents become patents.
International Cooperation in the Regulation of Nanotechnology
December 27, 2012
This article provides a broad overview of the general approach taken by major countries in the field of nanotechnology. It also describes steps taken in international cooperation in this area and suggests possible areas of international regulatory convergence.
Asbestos Payments Per Resolved Claim Increased 75% in the Past Year
December 27, 2012
An annual review of asbestos-related liabilities reported in companies' SEC filings, reveals that from 2010 to 2011, average payments per resolved claim increased 75%. Further review of the underlying data suggests that this increase in payments per claim is not due to a significant upward trend in asbestos liabilities. Instead, this increase can be explained by a change in the claim disease mix.
Drug & Device News
December 27, 2012
A discussion of several key cases.
Drug Marketing to Doctors: Changes May Be On the Way
December 27, 2012
The cornerstone of many FDA enforcement actions against pharmaceuticals manufacturers in recent years has been the charge that they have "misbranded" their pharmaceutical products by promoting them for uses not approved by the FDA. Now, the Second Circuit has thrown the concept of criminal liability for misbranding by means of off-label-use promotion into turmoil.
Insurance Coverage for Data Breach Claims
December 26, 2012
This article examines insurance coverage for data breaches. Counsel may be surprised to learn that coverage for data breaches is not limited to specialty policies, and can often be found under standard CGL or property insurance policies. Any time a potential data breach occurs, it is essential for an insured to consider all forms of insurance that it carries and to provide prompt notice to its insurer(s) of any policy that even potentially could apply.
An Analysis of the DOJ and SEC's Long-Awaited New FCPA Guidance
December 26, 2012
This article discusses some of the more significant issues that were addressed as well as the ones that were not addressed in as much detail as was hoped.
Drug Misbranding Redefined
December 26, 2012
The U.S. Court of Appeals for the Second Circuit has thrown the concept of criminal liability for misbranding by means of off-label-use promotion into turmoil in <i>United States v. Caronia.</i>

MOST POPULAR STORIES

  • Internet Goods and Product Liability
    The Internet's value arises in part from its ability to provide images, data and content quickly and at little cost. This ability results from the fact that Internet products — whether they be images, data or content — are each reduced to a digital format. Sharing products that have been so reduced may result in product liability.
    Read More ›
  • Understanding the Potential Pitfalls Arising From Participation in Standards Bodies
    Chances are that if your company is involved in research and development of new technology there is a standards setting organization exploring the potential standardization of such technology. While there are clear benefits to participation in standards organizations &mdash; keeping abreast of industry developments, targeting product development toward standard compliant products, steering research and intellectual property protection into potential areas of future standardization &mdash; such participation does not come without certain risks. Whether you are in-house counsel or outside counsel, you may be called upon to advise participants in standard-setting bodies about intellectual property issues or to participate yourself. You may also be asked to review patent policy of the standard-setting body that sets forth the disclosure and notification requirements with respect to patents for that organization. Here are some potential patent pitfalls that can catch the unwary off-guard.
    Read More ›